NCT03259230 2024-09-19Evaluation of IFNγ and Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic LymphohistiocytosisSwedish Orphan BiovitrumCompleted40 enrolled 43 charts
NCT01818492 2023-02-21Study to Investigate Safety, Efficacy of an Anti-IFNγ mAb in Children With Primary Haemophagocytic LymphohistiocytosisSwedish Orphan BiovitrumPhase 2/3 Completed45 enrolled 20 charts 1 FDA